Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity

Obesity Facts

Volumn 6, Issue 1, 2013, Pages 57-69

  Krist, Joanna ^a   Wieder, Katharina ^a   Klöting, Nora ^b   Oberbach, Andreas ^a   Kralisch, Susan ^a   Wiesner, Tobias ^a   Schön, Michael R ^c   Gärtner, Daniel ^c   Dietrich, Arne ^a   Shang, Edward ^a   Lohmann, Tobias ^d   Dreßler, Miriam ^d   Fasshauer, Mathias ^a   Stumvoll, Michael ^a   Blüher, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^d Municipal Clinic Dresden Neustadt   (Germany)

Author keywords

Adipokines; Apelin; Insulin resistance; Obesity; Visceral adipose tissue

Indexed keywords

APELIN; APELIN RECEPTOR; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MESSENGER RNA; TRIACYLGLYCEROL;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; EXERCISE; FAT CONTENT; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; WEIGHT REDUCTION; ADIPOSE TISSUE; AGED; CROSS-SECTIONAL STUDY; FAT MASS; GENE EXPRESSION; GLYCEMIC CONTROL; HUMAN TISSUE; INSULIN BLOOD LEVEL; LOW CALORY DIET; MACROPHAGE; OMENTAL ADIPOSE TISSUE; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; CALORIC RESTRICTION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; EXERCISE THERAPY; FEMALE; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRA-ABDOMINAL FAT; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SUBCUTANEOUS FAT; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84874003732     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000348667     Document Type: Article

References (32)

1. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M: Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476
2. Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C, Valet P: Apelin, diabetes, and obesity. Endocrine 2011; 40: 1-9
3. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O'Dowd BF: Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74: 34-41
4. Castan-Laurell I, Boucher J, Dray C, Daviaud D, Guigné C, Valet P: Apelin, a novel adipokine over-produced in obesity: Friend or foe? Mol Cell Endocrinol 2005; 245, 7-9
5. Tatemoto K: Search for an endogenous ligand of the orphan G protein-coupled receptor-discovery of apelin, a novel biologically active peptide. Nihon Rinsho 2000; 58: 737-46
6. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146: 1764-1771
7. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J, Beetz N, Musialek R, Neely GG, Komnenovic V, Kolm U, Metzler B, Ricci R, Hara H, Meixner A, Nghiem M, Chen X, Dawood F, Wong KM, Sarao R, Cukerman E, Kimura A, Hein L, Thalhammer J, Liu PP, Penninger JM: Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload. Circ Res 2007; 101:e32-42
8. Yue P, Jin H, Aillaud M, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, Tsao PS: Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 2010; 298:E59-E67
9. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, Soubrier F: Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 2008; 103: 432- 440
10. Principe A, Melgar-Lesmes P, Fernández-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jiménez W: The hepatic apelin system: A new therapeutic target for liver disease. Hepatology 2008; 48: 1193- 1201
11. Sorhede Winzell, M, Magnusson, C, Ahren, B: The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005; 131: 12-17
12. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, Cani PD, Attané C, Guigné C, Carpéné C, Burcelin R, Castan-Laurell I, Valet P: Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008; 8: 437-445
13. Attané C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, Guzmán-Ruiz R, Dray C, Bezaire V, Rancoule C, Kuba K, Ruiz-Gayo M, Levade T, Penninger J, Burcelin R, Pénicaud L, Valet P, Castan-Laurell I: Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 2012; 61: 310-320
14. Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M: Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2012; 61: 706-714
15. Harman-Boehm I, Blüher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Klöting N, Stumvoll M, Bashan N, Rudich A: Macrophage infiltration into omental versus subcutaneous fat across different populations: Effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23:S4-S19
17. Blüher M, Williams CJ, Klöting N, Hsi A, Ruschke K, Oberbach A, Fasshauer M, Berndt J, Schön MR, Wolk A, Stumvoll M, Mantzoros CS: Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 2007; 30: 3110-3115
18. Blüher M, Unger R, Rassoul F, Richter V, Paschke R: Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 2002; 45: 210-216
19. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, Stumvoll M, Blüher M: Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299:E506-E515
20. Castan-Laurell I, Vítkova M, Daviaud D, Dray C, Kováciková M, Kovacova Z, Hejnova J, Stich V, Valet P: Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol 2008; 158: 905-910
21. Heinonen MV, Laaksonen DE, Karhu T, Karhunen L, Laitinen T, Kainulainen S, Rissanen A, Niskanen L, Herzig KH: Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009; 19: 626-633
22. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ, Garcia- Fuentes E: Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009; 19: 1574-1580
23. Reinehr T, Woelfle J, Roth CL: Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: A longitudinal analysis. Metabolism 2011; 60: 1349-1354
24. Aydin S: The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus. Peptides 2010; 31: 2236-2240
25. Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, Szamatowicz J, Nikolajuk A, Zonenberg A, Zwierz-Gugala D, Jelski W, Laudański P, Wilczynski J, Kretowski A, Gorska M: Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010; 87: 176-183
26. Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attané C, Wanecq E, Guigné C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I: Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab 2010; 298:E1161-E1169
27. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K: Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006; 114: 544-548
28. Ercin CN, Dogru T, Tapan S, Kara M, Haymana C, Karadurmus N, Karslioglu Y, Acikel C: Plasma apelin levels in subjects with nonalcoholic fatty liver disease. Metabolism 2010; 59: 977-981
29. Zhang R, Hu C, Wang CR, Ma XJ, Bao YQ, Xu J, Lu JY, Qin W, Xiang KS, Jia WP: Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans. Chin Med J (Engl) 2009; 122: 1273- 1276
30. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J: The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749
31. Guo L, Li Q, Wang W, Yu P, Pan H, Li P, Sun Y, Zhang J: Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase- phosphodiesterase 3B. Endocr Res 2009; 34: 142-154
32. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009; 117: 241-250